SOPHiA GENETICS (NASDAQ: SOPH) is a health-tech software company that operates in the data-driven medicine sector. It has developed the universal SOPHiA DDM platform, a cloud-based software-as-a-service (SaaS) solution that uses advanced artificial intelligence and machine learning to analyze complex genomic and radiomic data, helping healthcare providers diagnose and treat diseases like cancer and inherited disorders.